Reported Jun 3, 2020 · Terminated
Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc.,…
Jubilant Cadista Pharmaceuticals, Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Jubilant Cadista Pharmaceuticals, Inc. · 207 Kiley Dr · Salisbury, MD · 21801-2249
Is this the product you have?
Lamotrigine TabletsUSP150 mg20000-count bulk container
- Manufactured byJubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA
- For repackaging byAvKare Inc., Pulaski, TN 38478, Bulk Shipment, NDC 59746-247-97
- Lot codes and dates
Lot #s 19P0437 & 19P0438Exp. 09/30/2021
- Amount recalled
- 1,313,333 tablets
Where it was sold
Why it was recalled
Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Jubilant Cadista Pharmaceuticals, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.